Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  VBI Vaccines Inc    

VBI VACCINES INC
Mes dernières consult.
Most popular
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets

VBI Vaccines Inc : Levi & Korsinsky, LLP Notifies Shareholders of VBI Vaccines Inc. of Commencement of an Investigation Concerning the Fairness of the Sale of the Company to SciVac Therapeutics Inc. -- VBIV

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/28/2015 | 06:40pm CEST

NEW YORK, NY / ACCESSWIRE / October 28, 2015 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased VBI Vaccines Inc. (NASDAQ: VBIV) stock prior to October 26, 2015.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of VBI Vaccines Inc. to SciVac Therapeutics Inc. for 20.808356 common shares of SciVac per share. VBI shareholders will own approximately 42% of the outstanding shares of the post-merger entity; VBI will survive as a subsidiary of SciVac and SciVac will change its name to VBI Vaccines Inc. To learn more about the investigation and your rights, go to: http://zlk.9nl.com/vbi-vaccines-vbiv, or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP


© Accesswire 2015
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on VBI VACCINES INC
2016 VBI VACCINES : Applies its eVLP Platform in the Development of a Novel Vaccine C..
2016 VBI VACCINES : Appoints Dr. Francisco Diaz-Mitoma as Chief Medical Officer
2016 VBI VACCINES : Applies its eVLP Platform in the Development of a Novel Vaccine C..
2016 VBI VACCINES : Researchers Explore the Mechanisms by Which CMV Infection May Imp..
2016 VBI VACCINES : Begins Enrolling Patients in a Phase I Trial of its Preventative ..
2016 VBI VACCINES : Announces Closing of $13.6 Million Private Placement
2016 VBI VACCINES : Begins Enrolling Patients in a Phase I Trial of its Preventative ..
2016 VBI VACCINES : Announces Closing of $13.6 Million Private Placement
2016 VBI VACCINES : to Present at the Virus-Like Particle and Nano-Particle Vaccines ..
2016 VBI VACCINES : to Host Hepatitis B Key Opinion Leader Meeting
More news
News from SeekingAlpha
2016 VBI VACCINES : Solid Drug Pipeline Backed By Key Investors That Control Billions
2016 Midday Gainers / Losers
2016 VBI Vaccines completes merger with SciVac
2016 VBI VACCINES : Better Price To Invest Alongside Strong Venture Funds In A Develo..
2016 VBI inks vaccine development deal with Glaxo; shares up 13% premarket
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price -
Spread / Average Target -100%
Sector and Competitors
1st jan.Capitalization (M$)
VBI VACCINES INC0
BIOGEN31.85%71 485
CSL LIMITED38.38%49 894
ALEXION PHARMACEUTICALS14.80%31 027
GRIFOLS SA30.11%17 818
BIOMARIN PHARMACEUTICAL6.98%15 380